Ya Chud and Polypharmacy Situation of Muang District in Suphanburi Province
Keywords:Ya Chud, polypharmacy, drug-related problems (DRPs), cardiovascular diseases
Ya Chud is a type of self-medication that is used to treat various ailments such as pain and common cold. It’s also considered a form of polypharmacy that is particularly affiliated with drug-related problems (DRPs). This cross-sectional study aimed to investigate the prevalence of Ya Chud use and polypharmacy situation, and assess the factors that were associated with this situation. In total, 353 people participated in the study. All participants lived in the Muang district, Suphanburi province. Data collection was performed using an interview questionnaire. We calculated descriptive statistics for general demographic information and the prevalence of medication use. Moreover, we utilized logistic regression to evaluate the factors related to polypharmacy. The majority of the participants were female, and about half of them were more than 60 years old. The prevalence of Ya Chud usage was about 37%. The symptoms or diseases of Ya Chud use were pain and the common cold. The prevalence of polypharmacy (using more than 5 medications) among Ya Chud users was 58.46%, while the prevalence was 32.58% among all participants. Having cardiovascular disease was associated with polypharmacy in the age-adjusted model (OR = 3.05, 95% CI = 1.28-7.59). Ya Chud use contributed to an increase in polypharmacy. To prevent and reduce this problem, health care practitioners should set up more vigorous programs on pharmacy health literacy to increase people’s awareness, particularly in those who have cardiovascular diseases. A surveillance system for polypharmacy and Ya Chud use would also help address this continuing problem in the community.
Chadbunchachai S. The behaviour of the people of NE Thailand towards medicines for self-treatment: Robert Gordon University; 1997.
Sringernyuang L, Hongvivatana T, Pradabmuk P, Drugs WHOAPoE. Implications of community health workers distributing drugs: a case study of Thailand / Luechai Sringernyuang, Thavitong Hongvivatana, Penchan Pradabmuk. Geneva: World Health Organization; 1994.
Sunpuwan M, Punpuing S, Jaruruengpaisan W, Kinsman J, Wertheim H. What is in the drug packet?: access and use of non-prescribed poly-pharmaceutical packs (Yaa Chud) in the community in Thailand. BMC Public Health. 2019; 19(1): 971.
World Health O. Guidelines for the regulatory assessment of medicinal products for use in self-medication. Geneva: World Health Organization; 2000.
Damkaew S. The use of Ya Chud among people in Tambon Khuanthani, Amphoe Kantang, Changwat Trang. Trang: Sirindhorn College of Public Health, Trang; 2018.
Bjerrum L, Sogaard J, Hallas J, Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol. 1998; 54(3): 197-202.
Brager R, Sloand E. The spectrum of polypharmacy. Nurse Pract. 2005; 30(6): 44-50.
Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005; 17(4): 123-32.
Jyrkka J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging. 2009; 26(12): 1039-1048.
Mason NA, Bakus JL. Strategies for reducing polypharmacy and other medication-related problems in chronic kidney disease. Semin Dial. 2010; 23(1): 55-61.
Faries D, Ascher-Svanum H, Zhu B, Correll C, Kane J. Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry. 2005; 5: 26.
Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001; 49(2): 200-209.
Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014; 13(1): 57-65.
Brekke M, Hunskaar S, Straand J. Self-reported drug utilization, health, and lifestyle factors among 70-74 year old community dwelling individuals in Western Norway. The Hordaland Health Study (HUSK). BMC Public Health. 2006; 6: 121.
Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005; 293(11): 1348-1358.
Flaherty JH, Perry HM, 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci. 2000; 55(10): M554-9.
Haider SI, Johnell K, Thorslund M, Fastbom J. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992 - 2002. Int J Clin Pharmacol Ther. 2007; 45(12): 643-53.
Hair JF, Black, W.C., Babin, B.J., Anderson, R.E. Multivariate Data Analysis. 7 ed: Harlow: Pearson Education Limited; 2014.
Haider SI, Johnell K, Thorslund M, Fastbom J. Analysis of the association between polypharmacy and socioeconomic position among elderly aged > or =77 years in Sweden. Clin Ther. 2008; 30(2): 419-427.
Jyrkka J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging. 2009; 26(6): 493-503.
Hayes BD, Klein-Schwartz W, Barrueto F, Jr. Polypharmacy and the geriatric patient. Clin Geriatr Med. 2007; 23(2): 371-390, vii.
Jyrkka J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study. Eur J Clin Pharmacol. 2006; 62(2): 151-158.
Walckiers D, Van der Heyden J, Tafforeau J. Factors associated with excessive polypharmacy in older people. Archives of public health = Archives belges de sante publique. 2015; 73:50.
Bourgeois FT, Shannon MW, Valim C, Mandl KD. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010; 19(9): 901-910.
Damian J, Pastor-Barriuso R, Valderrama-Gama E, de Pedro-Cuesta J. Factors associated with falls among older adults living in institutions. BMC Geriatr. 2013; 13: 6.
Fried TR, O'Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014; 62(12): 2261-2272.
Hovstadius B, Petersson G. The impact of increasing polypharmacy on prescribed drug expenditure-a register-based study in Sweden 2005-2009. Health Policy. 2013; 109(2): 166-174.
Jokanovic N, Tan EC, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review. J Am Med Dir Assoc. 2015; 16(6): 535 e1-12.
Lim LM, McStea M, Chung WW, Nor Azmi N, Abdul Aziz SA, Alwi S, et al. Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia. PLoS One. 2017; 12(3): e0173466.
Hammerlein A, Derendorf H, Lowenthal DT. Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications. Clin Pharmacokinet. 1998;35(1):49-64.
Turnheim K. Drug dosage in the elderly. Is it rational? Drugs Aging. 1998;13(5):357-379.
Rakleng S, Woradet S, Chaimay B. Prevalence of Using Polypharmacy in Diabetic Treatment among Diabetic Patients Type II in Phatthalung Province. Journal of Health Science. 2017; 26(6): 1073-1081.
Rakleng S. Polypharmacy and blood pressure control among hypertensive patients in Phatthalung Province. The Southern College Network Journal of Nursing and Public Health. 2017; 4.
How to Cite
Copyright (c) 2022 Health Science Journal of Thailand
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.